Gilead Sciences Inc’s experimental drug remdesivir, seen as one of the more promising potential treatments for the coronavirus, on Monday received the orphan drug designation from the U.S. Food and Drug Administration.
Click here for original story, Gilead’s potential coronavirus treatment gets FDA’s orphan drug label
Source: Reuters Science News